CAS 1196546-33-4

1-[4-[6-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]pyridin-2-yl]piperidin-4-ol

CAS: 1196546-33-4

1-[4-[6-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]pyridin-2-yl]piperidin-4-ol is a bioactive small molecule, typically synthesized in laboratories focusing on medicinal chemistry. This compound is specifically designed to interact with biochemical targets, usually proteins or receptors, to modulate their activity. Its mode of action involves binding to specific sites on these targets, potentially leading to inhibition, activation, or alteration of the target's natural function, depending on the desired therapeutic outcome. The applications of this compound are mainly situated in the realm of drug discovery and development, serving as a lead or candidate in the pursuit of effective therapies for conditions that involve the targeted pathways or receptors. Researchers analyze such compounds to assess their efficacy, selectivity, and therapeutic potential in disease models, which is critical in the preclinical stage of drug development.

Formula: C₃₁H₃₀FN₇O

Purezza: Min. 95%

Peso molecolare: 535.6 g/mol

Ref: 3D-WXB54633

GNF-8625

CAS: 1196546-33-4

GNE-8525: potent pan-TRK inhibitor, IC50=0.003 μM, effective in KM12 tumor model, targets oncogenic TRKA in various cancers.

Formula: C₃₁H₃₀FN₇O

Colore e forma: Solid

Peso molecolare: 535.61

Ref: TM-T71267